MannKind Corp. (MNKD)
4.075
-0.08
(-1.81%)
USD |
NASDAQ |
Aug 24, 16:00
4.075
0.00 (0.00%)
After-Hours: 20:00
MannKind 1 Year Total Returns (Daily) : 5.33% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 5.33% |
| August 20, 2026 | 7.30% |
| August 19, 2026 | 10.98% |
| August 18, 2026 | 6.82% |
| August 17, 2026 | 4.56% |
| August 14, 2026 | 4.05% |
| August 13, 2026 | 0.00% |
| August 12, 2026 | 5.19% |
| August 11, 2026 | 12.28% |
| August 10, 2026 | 11.65% |
| August 07, 2026 | 19.83% |
| August 06, 2026 | 12.27% |
| August 05, 2026 | 2.76% |
| August 04, 2026 | 1.02% |
| August 03, 2026 | 1.33% |
| July 31, 2026 | 3.44% |
| July 30, 2026 | 6.20% |
| July 29, 2026 | 0.79% |
| July 28, 2026 | -1.26% |
| July 27, 2026 | -2.71% |
| July 24, 2026 | 1.23% |
| July 23, 2026 | -5.12% |
| July 22, 2026 | -2.29% |
| July 21, 2026 | 6.02% |
| July 20, 2026 | 5.85% |
| Date | Value |
|---|---|
| July 17, 2026 | 3.33% |
| July 16, 2026 | 2.02% |
| July 15, 2026 | 6.23% |
| July 14, 2026 | -3.72% |
| July 13, 2026 | 7.16% |
| July 10, 2026 | 7.63% |
| July 09, 2026 | 8.38% |
| July 08, 2026 | 17.40% |
| July 07, 2026 | 19.21% |
| July 06, 2026 | 18.61% |
| July 02, 2026 | 24.86% |
| July 01, 2026 | 13.13% |
| June 30, 2026 | 13.90% |
| June 29, 2026 | 12.77% |
| June 26, 2026 | 9.81% |
| June 25, 2026 | 2.08% |
| June 24, 2026 | -3.76% |
| June 23, 2026 | 3.56% |
| June 22, 2026 | 3.18% |
| June 18, 2026 | 3.41% |
| June 17, 2026 | 4.53% |
| June 16, 2026 | 1.57% |
| June 15, 2026 | 7.82% |
| June 12, 2026 | -4.44% |
| June 11, 2026 | -3.35% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| United Therapeutics Corp. | 65.17% |
| ACADIA Pharmaceuticals, Inc. | 19.02% |
| Gilead Sciences, Inc. | 29.10% |
| Vertex Pharmaceuticals, Inc. | 37.89% |
| Ocugen, Inc. | 37.62% |